Holen Sie sich die Stockscreener-App
7.83
5.81%
0.43
Handel nachbörslich:
7.87
0.04
+0.51%
Schlusskurs vom Vortag:
$7.40
Offen:
$7.665
24-Stunden-Volumen:
1.87M
Relative Volume:
2.79
Marktkapitalisierung:
$462.55M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-153.16M
KGV:
-2.122
EPS:
-3.69
Netto-Cashflow:
$-134.48M
1W Leistung:
+34.08%
1M Leistung:
+19.91%
6M Leistung:
+1.56%
1J Leistung:
-51.73%
1-Tages-Spanne:
$7.37
$8.02
1-Wochen-Bereich:
$5.71
$8.02
52-Wochen-Spanne:
$5.68
$17.98
Cullinan Therapeutics Inc Stock (CGEM) Company Profile
Firmenname
Cullinan Therapeutics Inc
Sektor
Branche
Telefon
617-410-4650
Adresse
ONE MAIN STREET, CAMBRIDGE
Vergleichen Sie CGEM mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CGEM
Cullinan Therapeutics Inc
|
7.83 | 437.15M | 0 | -153.16M | -134.48M | -3.69 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.37 | 104.55B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
464.95 | 60.36B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
557.73 | 59.84B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
799.56 | 49.07B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
327.03 | 35.16B | 4.56B | -176.77M | 225.30M | -1.7177 |
Cullinan Therapeutics Inc Stock (CGEM) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-08-21 | Fortgesetzt | H.C. Wainwright | Buy |
| 2025-06-11 | Fortgesetzt | Stifel | Buy |
| 2024-10-24 | Eingeleitet | UBS | Buy |
| 2024-05-01 | Eingeleitet | Stifel | Buy |
| 2024-04-15 | Eingeleitet | William Blair | Outperform |
| 2024-02-15 | Eingeleitet | Wedbush | Outperform |
| 2023-06-15 | Eingeleitet | TD Cowen | Outperform |
| 2022-11-21 | Eingeleitet | BTIG Research | Buy |
| 2021-04-27 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2021-02-02 | Eingeleitet | Evercore ISI | Outperform |
| 2021-02-02 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2021-02-02 | Eingeleitet | SVB Leerink | Outperform |
| 2021-02-01 | Eingeleitet | H.C. Wainwright | Buy |
Alle ansehen
Cullinan Therapeutics Inc Aktie (CGEM) Neueste Nachrichten
Cullinan Therapeutics Cancer Drug Shows Efficacy In Brain Metastases Among Lung Cancer Patients With Certain Mutations - Benzinga
Is Cullinan Therapeutics Inc. stock a good choice for value investorsJuly 2025 News Drivers & Entry and Exit Point Strategies - newser.com
Visual analytics tools that track Cullinan Therapeutics Inc. performanceAnalyst Downgrade & Expert Curated Trade Ideas - newser.com
Cullinan Therapeutics Inc. stock prediction for this weekJuly 2025 Pullbacks & Free Growth Oriented Trading Recommendations - newser.com
Volume spikes in Cullinan Therapeutics Inc. stock – what they meanEarnings Performance Report & Free AI Powered Buy and Sell Recommendations - newser.com
Taiho Oncology, Cullinan: Zipalertinib 31.3% Intracranial ORR in NSCLC | CGEM Stock News - Stock Titan
Cullinan Therapeutics (NASDAQ:CGEM) Major Shareholder Buys $3,593,698.00 in Stock - MarketBeat
Lynx1 Capital Management Lp Buys 277,298 Shares of Cullinan Therapeutics (NASDAQ:CGEM) Stock - MarketBeat
Lynx1 capital buys Cullinan Therapeutics (CGEM) shares worth $9.8m By Investing.com - Investing.com South Africa
Lynx1 capital buys Cullinan Therapeutics (CGEM) shares worth $9.8m - Investing.com
Can machine learning forecast Cullinan Therapeutics Inc. recoveryDay Trade & Daily Profit Focused Screening - newser.com
How to forecast Cullinan Therapeutics Inc. trends using time series2025 Trade Ideas & Real-Time Chart Breakout Alerts - newser.com
Cullinan Therapeutics Inc. stock momentum explainedEarnings Performance Report & Weekly Momentum Stock Picks - newser.com
Cullinan Therapeutics (NASDAQ:CGEM) Receives Sell (E+) Rating from Weiss Ratings - MarketBeat
Reversal indicators forming on Cullinan Therapeutics Inc. stock2025 Volatility Report & Verified Entry Point Signals - newser.com
Published on: 2025-09-29 10:05:02 - newser.com
Cullinan Therapeutics Inc Stock Analysis and ForecastSupport Level Holds & Free Stock Education Platform for New Investors - earlytimes.in
What analysts say about Cullinan Therapeutics Inc stockCandlestick Pattern Analysis & Small Budget Wealth Building - earlytimes.in
How to use a screener to detect Cullinan Therapeutics Inc. breakoutsQuarterly Market Review & Capital Efficiency Focused Strategies - newser.com
How moving averages guide Cullinan Therapeutics Inc. tradingMarket Performance Report & High Accuracy Investment Signals - newser.com
Published on: 2025-09-26 16:18:03 - newser.com
Multi asset correlation models including Cullinan Therapeutics Inc.July 2025 Highlights & Daily Stock Trend Watchlist - newser.com
Cullinan Therapeutics, Inc. $CGEM Shares Bought by Rhumbline Advisers - Defense World
Using R and stats models for Cullinan Therapeutics Inc. forecastingLong Setup & Entry Point Confirmation Signals - newser.com
BDTX vs. Cullinan Therapeutic: Which EGFR Challenger Is the Better Buy? - sharewise.com
Cullinan Therapeutics (NASDAQ:CGEM) Raised to Hold at Zacks Research - MarketBeat
Cullinan Therapeutics Hits New 52-Week Low at $6.32 - Markets Mojo
Cullinan Therapeutics, Inc. (NASDAQ:CGEM) Receives $26.00 Consensus Price Target from Analysts - MarketBeat
Cullinan Therapeutics Hits New 52-Week Low at $5.89 - Markets Mojo
Cullinan Therapeutics Hits New 52-Week Low at $6.24 Amidst Major Decline - Markets Mojo
using r and stats models for cullinan therapeutics inc. forecastingTrade Volume Report & Weekly Market Pulse Updates - newser.com
Best data tools to analyze Cullinan Therapeutics Inc. stock2025 Market Sentiment & Risk Adjusted Buy and Sell Alerts - newser.com
Can Cullinan Therapeutics Inc withstand a market correctionJuly 2025 News Drivers & Long-Term Growth Plans - خودرو بانک
Can technical indicators confirm Cullinan Therapeutics Inc.’s reversalInsider Selling & Daily Chart Pattern Signal Reports - newser.com
Breakouts Watch: Can Cullinan Therapeutics Inc outperform under higher oil prices2025 Historical Comparison & Weekly High Return Stock Forecasts - خودرو بانک
Downgrade Watch: What is the Moat Score of Cullinan Therapeutics Inc2025 Major Catalysts & Technical Pattern Recognition Alerts - khodrobank.com
New Highs: Is Cullinan Therapeutics Inc benefiting from innovation trends2025 Performance Recap & Smart Investment Allocation Tips - خودرو بانک
Published on: 2025-09-20 04:22:55 - خودرو بانک
Is Cullinan Therapeutics Inc. still worth holding after the dip2025 Biggest Moves & Trade Opportunity Analysis Reports - newser.com
Pullback Watch: Will Cullinan Therapeutics Inc. benefit from government policy2025 Market Sentiment & Stock Timing and Entry Methods - خودرو بانک
Analyzing recovery setups for Cullinan Therapeutics Inc. investors2025 Technical Overview & Real-Time Market Sentiment Alerts - newser.com
Market Pulse: Is DBVT subject to activist investor interest2025 Macro Impact & AI Driven Price Forecasts - khodrobank.com
Aug Chart Watch: Whats the RSI of Cullinan Therapeutics Inc stockQuarterly Growth Report & Fast Moving Stock Watchlists - خودرو بانک
Performance Recap: What is Cullinan Therapeutics Incs valuation compared to sectorMarket Performance Recap & High Return Stock Watch Alerts - khodrobank.com
Cullinan Therapeutics (NASDAQ:CGEM) Upgraded at Zacks Research - Defense World
Sentiment Recap: Does Cullinan Therapeutics Inc have strong EBITDA margins2025 Technical Overview & Weekly High Conviction Trade Ideas - خودرو بانک
Finanzdaten der Cullinan Therapeutics Inc-Aktie (CGEM)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):